Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Vaccines for Pseudomonas aeruginosa: a long and winding road.

Priebe GP, Goldberg JB.

Expert Rev Vaccines. 2014 Apr;13(4):507-19. doi: 10.1586/14760584.2014.890053. Epub 2014 Feb 27. Review.

2.

Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes.

Lu Q, Eggimann P, Luyt CE, Wolff M, Tamm M, Fran├žois B, Mercier E, Garbino J, Laterre PF, Koch H, Gafner V, Rudolf MP, Mus E, Perez A, Lazar H, Chastre J, Rouby JJ.

Crit Care. 2014 Jan 15;18(1):R17. doi: 10.1186/cc13697.

3.

Identification of the mutation responsible for the temperature-sensitive lipopolysaccharide O-antigen defect in the Pseudomonas aeruginosa cystic fibrosis isolate 2192.

Davis MR Jr, Muszynski A, Lollett IV, Pritchett CL, Carlson RW, Goldberg JB.

J Bacteriol. 2013 Apr;195(7):1504-14. doi: 10.1128/JB.01999-12. Epub 2013 Jan 25.

4.

Spread of multidrug-resistant Pseudomonas aeruginosa clones in a university hospital.

Koutsogiannou M, Drougka E, Liakopoulos A, Jelastopulu E, Petinaki E, Anastassiou ED, Spiliopoulou I, Christofidou M.

J Clin Microbiol. 2013 Feb;51(2):665-8. doi: 10.1128/JCM.03071-12. Epub 2012 Dec 12.

5.

Serotyping and Cross-Reactivity's Between Different Pseudomonas aeruginosa Isolates Prevalent in Iran.

Ahmadi H, Maleknia S, Tabaraie B, Norouzian D, Poormirza-Gholi F, Nejati M, Hedayati M, Beik Mohammadi M, Behnoodi A, Izadpanahi M.

Iran J Microbiol. 2010 Jun;2(2):85-8.

6.

Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235.

Maatallah M, Cheriaa J, Backhrouf A, Iversen A, Grundmann H, Do T, Lanotte P, Mastouri M, Elghmati MS, Rojo F, Mejdi S, Giske CG.

PLoS One. 2011;6(10):e25617. doi: 10.1371/journal.pone.0025617. Epub 2011 Oct 3.

7.

Pseudomonas aeruginosa: so many virulence factors, so little time.

Hauser AR.

Crit Care Med. 2011 Sep;39(9):2193-4. doi: 10.1097/CCM.0b013e318221742d. No abstract available.

8.

Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.

Kamei A, Coutinho-Sledge YS, Goldberg JB, Priebe GP, Pier GB.

Infect Immun. 2011 Mar;79(3):1289-99. doi: 10.1128/IAI.01139-10. Epub 2010 Dec 13.

9.

Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice.

Scarff JM, Goldberg JB.

Clin Vaccine Immunol. 2008 Feb;15(2):367-75. Epub 2007 Dec 19.

10.

Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections.

DiGiandomenico A, Rao J, Harcher K, Zaidi TS, Gardner J, Neely AN, Pier GB, Goldberg JB.

Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4624-9. Epub 2007 Mar 5.

11.

Acquisition and evolution of the exoU locus in Pseudomonas aeruginosa.

Kulasekara BR, Kulasekara HD, Wolfgang MC, Stevens L, Frank DW, Lory S.

J Bacteriol. 2006 Jun;188(11):4037-50.

Items per page

Supplemental Content

Write to the Help Desk